highly significantp < 0.01
The highly significant hazard ratio of 3.6 ( p < 0.01) indicates a markedly faster progression rate in the high-risk group compared to the moderate/low-risk group (Fig. 4b ).
The highly significant hazard ratio of 3.6 ( p < 0.01) indicates a markedly faster progression rate in the high-risk group compared to the moderate/low-risk group (Fig. 4b ).
Although the effects in the future CKD group were not statistically significant but near significance ( p < 0.1, Table 6) , there was a noticeable trend involving the same lipid metabolism GMF.
We attribute this to the relatively smaller sample size of patients taking SGLT2i in the future CKD group compared to the future non-CKD group ( n = 16 vs n = 23), causing the effects within the future CKD group to be non-significant but approaching significance ( p < 0.1).